RxDoctor Payments Data

Angela Chin, PA

Physician Assistant · Oakland, CANPI 1891173027

Payments from drug & device makers

$806in general payments, 2019–2025

Across 11 payments — averaging $73.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Irhythm Technologies, Inc.$211
  • Heartflow, Inc.$167
  • Medtronic$164
  • Boehringer Ingelheim$121
  • Abbott$85
  • Boston Scientific$38
  • plus $20 from 1 others

What the payments were for

  • Food & beverage$806100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$806 in reported general payments places this provider in the 70th percentile of 10,423 physician assistant providers in California.

See all physician assistant providers in California

Medicare billing

Part B allowed, 2024
$88,534
Medicare patients
527
Services billed
748

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban328$451,730
XareltoRivaroxaban162$207,984
EntrestoSacubitril/Valsartan72$88,543
MultaqDronedarone Hcl46$88,522
JardianceEmpagliflozin31$32,469
FarxigaDapagliflozin Propanediol19$26,810
Repatha SureclickEvolocumab14$20,902
BrilintaTicagrelor14$13,178
Praluent PenAlirocumab13$6,956
Metoprolol Succinate299$5,126
Propafenone Hcl ErPropafenone Hcl11$4,784
Potassium Chloride53$3,614
Atorvastatin Calcium254$3,197
Carvedilol216$2,070
Amiodarone Hcl53$1,713

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$121$32,46931 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 10,423 physician assistant providers in California.

Other physician assistant in Oakland

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →